FLXN
Flexion Therapeutics, Inc.
FLXN
FLXN
Delisted
FLXN was delisted on the 18th of November, 2021.
133 hedge funds and large institutions have $670M invested in Flexion Therapeutics, Inc. in 2019 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 28 increasing their positions, 42 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
133
Holders Change
+7
Holders Change %
+5.56%
% of All Funds
2.63%
Holding in Top 10
4
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+300%
% of All Funds
0.08%
New
30
Increased
28
Reduced
42
Closed
21
Calls
$19M
Puts
$4.7M
Net Calls
+$14.3M
Net Calls Change
+$9.83M
Top Buyers
| 1 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$17.3M |
| 2 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$6.43M |
| 3 |
SAM
Silvercrest Asset Management
New York
|
+$4.41M |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$4.03M |
| 5 |
State Street
Boston,
Massachusetts
|
+$3.79M |
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$20.4M |
| 2 |
Bank of New York Mellon
New York
|
-$12.2M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$11M |
| 4 |
CC
Clearline Capital
New York
|
-$10.9M |
| 5 |
RCMNY
Rubric Capital Management (New York)
New York
|
-$9.82M |
